MedPath

Impact of Dietary Fibre Consumption on Digestive Comfort

Not Applicable
Recruiting
Conditions
Gastrointestinal Discomfort
Interventions
Dietary Supplement: Inulin
Dietary Supplement: soluble corn fibre and inulin
Dietary Supplement: Soluble corn fibre
Dietary Supplement: Maltodextrin
Registration Number
NCT05830032
Lead Sponsor
University of Glasgow
Brief Summary

The purpose of this randomised, placebo-controlled, cross-over study is to compare the impact different fibres have on gastrointestinal symptoms when they are consumed individually or as mixtures in healthy adults. The impact of different fibres on the experience of symptoms and stool parameters will be assessed.

Detailed Description

Global sugar consumption is higher than recommended and there are suggestions that this may be linked to the development of non-communicable diseases including dental caries, and obesity. There are many alternatives to sugars that can be used in foods including certain dietary fibres such as inulin or fructo-oligosaccharides. Most dietary fibres can be fully or partially fermented in the colon by the commensal microbiota, producing beneficial bioactive molecules. However, the rapid production of gas during the fermentation of highly soluble fermentable fibres may cause undesirable symptoms for some people. Dietary exposure to the fibres used in food reformulation, including inulin and soluble corn fibre, is increasing and the impact this may have on gastrointestinal symptoms is unclear. The impact of fibres with different physicochemical characteristics and fermentabilities may differ when consumed in mixtures compared to individually.

The aim of this study is to investigate the impact different fibres have on gastrointestinal symptoms when they are consumed individually or as mixtures and how this relates to the composition of the stool.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
12
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
InulinInulinInulin (In) (15g fibre/day)
Soluble corn fibre and inulinsoluble corn fibre and inulinSCF + In (15g/day fibre)
Soluble Corn fibreSoluble corn fibreSoluble corn fibre (SCF) (15g fibre/day)
Control (Maltodextrin)MaltodextrinControl (Maltodextrin) (0g fibre)
Primary Outcome Measures
NameTimeMethod
Symptom frequency and intensity scoresover 7 days

Symptom frequency and intensity scores for abdominal pain, abdominal bloating and flatulence individually will be reported during each 7-day feeding period. Symptoms will be analysed individually and in combination to create a composite score using a visual analogue scale. This entails making a mark on a horizontal line of 10cm indicating 0 (no symptom) to 10 (worst imaginable symptom). Participants will record the occurrence of each symptom and rate the severity using this scale. The combined score is the sum of each of the symptoms.

Secondary Outcome Measures
NameTimeMethod
Stool frequencyover 7 days

Diary

Stool form using the Bristol stool chartOver 7 days

Diary for each event

Stool water contentDay 1 and day 7

2 samples each week

Stool acidityDay 1 and day 7

2 samples each week

Stool SCFA concentrationsDay 1 and day 7

2 samples each week

Trial Locations

Locations (1)

Human Nutrition New Lister Building

🇬🇧

Glasgow, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath